Yahoo
Shanghai - Delayed Quote CNY

Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS)

12.21 +0.66 (+5.71%)
At close: 3:00:02 PM GMT+8
Chart Range Bar
Loading chart for 601567.SS
  • Previous Close 11.55
  • Open 11.70
  • Bid 12.20 x --
  • Ask 12.21 x --
  • Day's Range 11.65 - 12.28
  • 52 Week Range 11.38 - 33.66
  • Volume 20,259,063
  • Avg. Volume 18,106,029
  • Market Cap (intraday) 17.158B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 38.16
  • EPS (TTM) 0.32
  • Earnings Date --
  • Forward Dividend & Yield 0.63 (5.45%)
  • Ex-Dividend Date Jun 10, 2026
  • 1y Target Est 22.03

Ningbo Sanxing Medical Electric Co.,Ltd. manufactures and sells power distribution in China and internationally. The company offers prepaid. ANSI, classical, photovoltaic, and smart meters; data concentrator units, CIUS, and modules; and DC and AC chargers. It also provides AMI and smart prepayment solutions under the SanPlat name; Wi-SUN solution comprising smart meters, communication modules, gateways, repeaters, and network management systems; and FDM solutions. In addition, the company offers charging station and dynamic load balance solutions. Further, it provides financial leasing and consulting services, as well as medical services. The company was formerly known as Ningbo Sanxing Electric Co., Ltd. and changed its name to Ningbo Sanxing Medical Electric Co.,Ltd. in October 2015. Ningbo Sanxing Medical Electric Co.,Ltd. was founded in 1986 and is based in Ningbo, China.

www.sanxing.com

12,843

Full Time Employees

December 31

Fiscal Year Ends

Industrials

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

601567.SS
46.43%
SSE Composite Index (000001.SS)
8.34%

1-Year Return

601567.SS
44.98%
SSE Composite Index (000001.SS)
8.01%

3-Year Return

601567.SS
16.63%
SSE Composite Index (000001.SS)
20.89%

5-Year Return

601567.SS
9.86%
SSE Composite Index (000001.SS)
3.78%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 3.07B
Earnings 153.8M
Profit Margin 5.02%

Q2

FY25

Q3

FY25

Q4

FY25

Q3

FY26

0
1B
2B
3B
4B
-5.0%
0.0%
5.0%
10.0%
15.0%

Analyst Insights

View More

Analyst Price Targets

14.00
22.03 Average
12.21 Current
32.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.27%

  • Return on Assets (ttm)

    1.57%

  • Return on Equity (ttm)

    3.61%

  • Revenue (ttm)

    13.61B

  • Net Income Avi to Common (ttm)

    445.79M

  • Diluted EPS (ttm)

    0.32

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.71B

  • Total Debt/Equity (mrq)

    28.68%

  • Levered Free Cash Flow (ttm)

    368.92M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: